Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During Phacoemulsification
- Conditions
- Intraoperative Performance and Postoperative Outcomes Following Cataract Surgery
- Interventions
- Procedure: Microcoaxial Phacoemulsification
- Registration Number
- NCT01664689
- Lead Sponsor
- Iladevi Cataract and IOL Research Center
- Brief Summary
Ophthalmic Viscosurgical Devices (OVDs) play a crucial role during phacoemulsification, by providing endothelial protection, maintaining space, as well as facilitating surgical maneuvers, including IOL implantation. Equally important is the ease of use, good visualisation and easy removal of the OVD from the eye. Currently, 3 popularly used OVDs as a single injection sufficing for surgery are: Healon 5, DiscoVisc, and Celoftal (2% hydroxypropylmethylcellulose). Whereas, there are studies showing efficacy of each of these in clinical scenarios, there is no randomized trial comparing intraoperative performance and postoperative outcomes. The aim of this study was to compare intraoperative performance and postoperative outcomes following microcoaxial phacoemulsification when using one of the three OVDs
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Age related, uncomplicated senile cataracts
- presence of glaucoma,
- shallow anterior chamber (ACD < 2.1mm),
- pupillary dilatation < 6mm,
- extremely dense cataracts,
- posterior polar cataract,
- subluxated cataract,
- white mature cataract,
- diabetic retinopathy,
- high myopia (defined as AL > 25mm),
- uveitis, or
- previous ocular trauma/surgery.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description DiscoVisc Microcoaxial Phacoemulsification microcoaxial phacoemulsification performed with discovisc Healon 5 Microcoaxial Phacoemulsification microcoaxial phacoemulsification using healon 5 Celoftal Microcoaxial Phacoemulsification microcoaxial phacoemulsification using celoftal
- Primary Outcome Measures
Name Time Method Corneal clarity on postoperative day 1 postoperative day 1
- Secondary Outcome Measures
Name Time Method Central corneal thickness on postoperative day 1 and week 1 day 1 and week 1
Trial Locations
- Locations (1)
Iladevi Cataract & IOL Research Centre
🇮🇳Ahmedabad, Gujarat, India